Bio/pharma companies and their suppliers are facing key challenges and opportunities as digital transformation, including artificial intelligence (AI), emerging technologies, and ever-changing global supply lines, reshape the bio/pharmaceutical value chain. The DCAT Global Summit 2026: THE FUTURE OF BIO/PHARMA: Mastering the Supply Chain, Digitalization & Global Shifts, which will be held 10-ll June 2026, in Barcelona, Sitges will bring together industry and thought leaders to share practical insights and first-hand experience into how to adapt now and be future-ready to these competitive forces. The Summit will explore the current and future use of AI and other digital technologies in accelerating timelines in R&D, improving manufacturing, and enhancing supply-chain performance and how the rising digital bar will impact the way business is done between bio/pharma companies and their suppliers, including in reskilling for digitalization. The Summit will also examine what is top-of-mind for the industry: strengthening supply-chain resilience amid geopolitical and trade uncertainty, strategies for de-risking supply chains, and the financial and market impact of shifting global supply lines.
“The DCAT Summit was unlike any other—an inspiring convergence of visionary speakers, fresh perspectives, and meaningful dialogue. The breadth of presentations opened my mind to new possibilities, and the opportunity to connect with senior leaders left me energized and motivated to shape the future of our industry.”
- Stacey R. Vaughan West Pharmaceutical Services, Inc.
“The DCAT Summit was one of the most impactful conferences I have attended. The combination of education, networking, and the open sharing of opinions left me feeling incredibly upbeat about the future of the pharmaceutical industry.”
- 2025 DCAT Summit Attendee
